William Hoffman, Director at Inari Medical, Inc. (NARI), sold 50,000 shares at $56.93 ($2.9M) on 2023-07-17, disclosed to the SEC on 2023-07-19.
Scheduled sale ($2.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.80 | 6,803 | $386K | 13.5% |
| 2 | $56.80 | 6,803 | $386K | 13.5% |
| 3 | $56.93 | 10,841 | $617K | 21.6% |
| 4 | $56.93 | 10,841 | $617K | 21.6% |
| 5 | $57.52 | 3,197 | $184K | 6.4% |
| 6 | $57.52 | 3,197 |
| $184K |
| 6.4% |
| 7 | $57.57 | 4,159 | $239K | 8.4% |
| 8 | $57.57 | 4,159 | $239K | 8.4% |
| Total | $57.08 avg | 50,000 | $2.9M | 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |